drugset / Trial / NCT00933413

Dermacyd Silver Frutal (Lactic Acid) - Acceptability.

NCT00933413

Phase 3 Completed 30 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Primary Objective: To prove the safety of the gynecological formulation in normal conditions of use.

Timeline

Start
2009-06
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified

Indications

No indication recorded.